SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009931
Filing Date
2022-05-16
Accepted
2022-05-16 06:43:39
Documents
69
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q elym-20220331.htm   iXBRL 10-Q 2702350
2 EX-31.1 elym-ex31_1.htm EX-31.1 19565
3 EX-31.2 elym-ex31_2.htm EX-31.2 19616
4 EX-32.1 elym-ex32_1.htm EX-32.1 12535
5 EX-32.2 elym-ex32_2.htm EX-32.2 12613
6 GRAPHIC img156753201_0.jpg GRAPHIC 339686
  Complete submission text file 0000950170-22-009931.txt   9955072

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elym-20220331_pre.xml EX-101.PRE 310310
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elym-20220331_def.xml EX-101.DEF 149028
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elym-20220331.xsd EX-101.SCH 53624
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elym-20220331_lab.xml EX-101.LAB 407839
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elym-20220331_cal.xml EX-101.CAL 40871
63 EXTRACTED XBRL INSTANCE DOCUMENT elym-20220331_htm.xml XML 1904622
Mailing Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053
Business Address 23515 NE NOVELTY HILL ROAD SUITE B221 #125 REDMOND WA 98053 425-276-2300
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40708 | Film No.: 22925334
SIC: 2834 Pharmaceutical Preparations